Stonebridge Capital Advisors LLC Has $9.61 Million Position in iShares S&P 500 Index (IVV)

Stonebridge Capital Advisors LLC increased its position in iShares S&P 500 Index (NYSEARCA:IVV) by 9.9% in the fourth quarter, Holdings Channel reports. The institutional investor owned 35,756 shares of the company’s stock after buying an additional 3,230 shares during the quarter. iShares S&P 500 Index comprises 2.2% of Stonebridge Capital Advisors LLC’s holdings, making the stock its 5th largest position. Stonebridge Capital Advisors LLC’s holdings in iShares S&P 500 Index were worth $9,613,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. Moller Financial Services lifted its position in iShares S&P 500 Index by 1.0% in the fourth quarter. Moller Financial Services now owns 127,119 shares of the company’s stock valued at $34,176,000 after purchasing an additional 1,241 shares during the last quarter. Rezny Wealth Management Inc. lifted its position in iShares S&P 500 Index by 3.3% in the fourth quarter. Rezny Wealth Management Inc. now owns 63,241 shares of the company’s stock valued at $17,002,000 after purchasing an additional 2,026 shares during the last quarter. Boston Family Office LLC lifted its position in iShares S&P 500 Index by 59.1% in the fourth quarter. Boston Family Office LLC now owns 1,435 shares of the company’s stock valued at $386,000 after purchasing an additional 533 shares during the last quarter. Hefty Wealth Partners lifted its position in iShares S&P 500 Index by 4.4% in the fourth quarter. Hefty Wealth Partners now owns 10,575 shares of the company’s stock valued at $2,843,000 after purchasing an additional 446 shares during the last quarter. Finally, Vista Capital Partners Inc. increased its stake in shares of iShares S&P 500 Index by 16.0% during the fourth quarter. Vista Capital Partners Inc. now owns 2,814 shares of the company’s stock valued at $637,000 after buying an additional 389 shares during the period.

How to Become a New Pot Stock Millionaire

Shares of iShares S&P 500 Index (NYSEARCA:IVV) opened at $265.47 on Friday. The firm has a market capitalization of $158,180.00 and a price-to-earnings ratio of 11.75. iShares S&P 500 Index has a 12 month low of $233.10 and a 12 month high of $288.69.

WARNING: This story was published by Ticker Report and is owned by of Ticker Report. If you are reading this story on another publication, it was stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this story can be read at https://www.tickerreport.com/banking-finance/3293614/stonebridge-capital-advisors-llc-has-9-61-million-position-in-ishares-sp-500-index-ivv.html.

About iShares S&P 500 Index

iShares Core S&P 500 ETF (the Fund) is an exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Standard & Poor’s 500 Index (the Index). The Index measures the performance of the large-capitalization sector of the United States equity market.

Want to see what other hedge funds are holding IVV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares S&P 500 Index (NYSEARCA:IVV).

Institutional Ownership by Quarter for iShares S&P 500 Index (NYSEARCA:IVV)

Receive News & Ratings for iShares S&P 500 Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares S&P 500 Index and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Q1 2019 Earnings Forecast for Loblaw Companies Issued By National Bank Financial
Q1 2019 Earnings Forecast for Loblaw Companies Issued By National Bank Financial
Research Analysts Set Expectations for Lam Research’s Q4 2018 Earnings
Research Analysts Set Expectations for Lam Research’s Q4 2018 Earnings
HSBC Downgrades KAZ Minerals  to Reduce
HSBC Downgrades KAZ Minerals to Reduce
Medallion Financial  Downgraded to “Sell” at Zacks Investment Research
Medallion Financial Downgraded to “Sell” at Zacks Investment Research
Zacks Investment Research Upgrades Moleculin Biotech  to Buy
Zacks Investment Research Upgrades Moleculin Biotech to Buy
Rio Tinto  PT Set at GBX 4,200 by Cfra
Rio Tinto PT Set at GBX 4,200 by Cfra


© 2006-2018 Ticker Report. Google+.